Spectral CT Clinical Trial Protocol

Philips

Status: Terminated

Conditions: CT Scanning

Treatments: Device: Spectral CT

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT05017233

PD_CT_Hawk_2021_11258

Details and patient eligibility

About

The purpose of this study was to evaluate the expected effectiveness, ease of operation, stability, and safety of Spectral CT

Full description

Under the premise of protecting subjects and ensuring the scientific nature of this study, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal conditions by collecting clinical cases.

Enrollment: 51 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Recruit volunteers (ages 18 to 75);
• Negative pregnancy tests in women of childbearing age;
• Participants who agree to participate in this clinical trial and sign the informed consent;
• Enhanced scans require laboratory tests to confirm normal renal function.

Exclusion criteria

• Persons who do not have full capacity for civil conduct;
• Lactating women;
• People who are not suitable for enhanced scanning with iodine contrast agent;
• Patients whom the investigator considers inappropriate to participate in this clinical trial.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

51 participants in 1 patient group

Experimental group, all volunteer will be scanned.

Experimental group

Description:

All participation accept Spectral CT scanning; No group;

Treatment:

Device: Spectral CT